Clinical Trials Logo

Filter by:
NCT ID: NCT05653713 Completed - Healthy Volunteers Clinical Trials

Effects of CSL324 in the Lung After Segmental Challenge

Start date: December 20, 2022
Phase: Phase 1
Study type: Interventional

This is a phase 1b, randomized, double-blind, placebo-controlled study in healthy volunteers to investigate the antiinflammatory effect of pretreatment with CSL324 on response to a lipopolysaccharide (LPS) endotoxin challenge in a single lung segment. Saline will be instilled into a segment in the contralateral lung for the purpose of comparison.

NCT ID: NCT05650294 Completed - Pharmacokinetics Clinical Trials

Uptake of an Omega-3 Oil in Healthy Adults

Start date: January 9, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to compare the uptake of two different omega-3 fatty acid preparations in healthy adults. The main question it aims to answer is whether the two different preparations have the same uptake after single dose supplementation.

NCT ID: NCT05644444 Completed - Dyspareunia Clinical Trials

Effectiveness and Safety of a Water-based and a Silicone-based Personal Lubricants With Sensory Action

Start date: February 20, 2023
Phase: N/A
Study type: Interventional

This clinical investigation will look at the effectiveness and safety of two personal lubricants for the relief of intimate discomfort associated with vaginal dryness.

NCT ID: NCT05643313 Completed - Clinical trials for Spinal Cord Injuries

Clinical Investigation on Feasibility and Usability of the ABLE Exoskeleton Device for Individuals With Spinal Cord Injury to Perform Skills for Home and Community Environments

Start date: November 25, 2022
Phase: N/A
Study type: Interventional

The loss of the ability to walk and the associated restriction of mobility presents a major challenge to people with spinal cord injury in an everyday environment designed for pedestrians. Exoskeletal technology has the potential to help people with impaired leg function to regain ambulation and thus improve their independence. This technology is not completely new, but due to their high access price (~120k€/unit), high size and weight (~25 kg), and need for trained physiotherapist supervision, commercially available exoskeletons are only found in large hospitals and only in very few cases get into patients' homes. The company ABLE Human Motion S.L. (Barcelona, Spain) has developed a novel exoskeleton to overcome these disadvantages, which is more compact, lighter and easier to use. The primary objective of this study is to determine the feasibility and usability of the ABLE Exoskeleton for persons with SCI to perform skills in home and community environments.

NCT ID: NCT05640245 Completed - Clinical trials for Arthritis, Psoriatic

Evaluation of Sonelokimab for the Treatment of Patients With Active Psoriatic Arthritis

Start date: December 13, 2022
Phase: Phase 2
Study type: Interventional

This is a study to demonstrate the clinical efficacy and safety of the nanobody® sonelokimab administered subcutaneously (sc) compared with placebo in the treatment of adult participants with active psoriatic arthritis. The study includes adalimumab treatment as an active reference arm.

NCT ID: NCT05635500 Completed - Clinical trials for Intubation; Difficult or Failed

Clinical Comparison Between Midline and Right-sided Insertion of the Videolaryngoscope for Endotracheal Intubation

Midway
Start date: August 1, 2021
Phase: N/A
Study type: Interventional

The videolaryngoscope is an established tool for securing the airway, even in difficult situations. It remains unclear which insertion technique is the safest and fastest in the difficult airway.

NCT ID: NCT05635305 Completed - Healthy Volunteers Clinical Trials

Zoliflodacin Bioequivalence and Drug-Drug Interaction Study

Start date: November 9, 2022
Phase: Phase 1
Study type: Interventional

this study will be a Phase 1, single-dose, two parallel cohorts, open-label, randomized study in healthy subjects with Cohort 1 as bioequivalence (BE) and food effect study and Cohort 2 as a drug-drug interaction (DDI) study.

NCT ID: NCT05634187 Completed - Clinical trials for Reflux, Gastroesophageal

One-stop-shop Endoscopy in Reflux-patients: Evaluation of ENT and GI Features

ENTGI-reflux
Start date: November 20, 2022
Phase:
Study type: Observational

Patients suffering from gastroesophageal reflux may suffer from both esophageal and laryngeal irritations. The investigators developed an endoscopic technique called functional endoscopy to evaluate alterations in the larynx and pharynx as well as in the esophagus simultaneously as one-stop-shop.

NCT ID: NCT05630378 Completed - COVID-19 Clinical Trials

Evaluation of an Integrative Medicine Outpatient Clinical Setting for Post-COVID-19 Patients

TaPoCo
Start date: May 11, 2022
Phase: N/A
Study type: Interventional

The study aims to identify whether a multimodal integrative naturopathy outpatient clinical concept can improve the symptoms of patients suffering from post-COVID-Syndrome. Main outcome is fatigue. The outpatient clinical programme consists of 11 weeks wherein patients visit the clinic one day per week. The pillars of classical naturopathy are combined with extended naturopathy and complementary procedures. Previous naturopathical studies on patients with chronic fatigue syndrome could find numerous indications that different types of naturopathy can help patients with fatigue.

NCT ID: NCT05627609 Completed - Multiple Sclerosis Clinical Trials

Sunlight-mediated Inter-organ Leukocyte Exchange

SMILE
Start date: November 21, 2022
Phase: N/A
Study type: Interventional

Ultraviolet B (UVB) irradiation induces regulatory immune cell types that may transmigrate from the skin to the blood and to the central nervous system and exert regulatory effects. Vitamin D deficiency-associated gene variants should reduce this effect if this is mediated by vitamin D. For this study, participants will be irradiated with UVB for 4 weeks. Single cell RNA Sequencing will be performed on isolated immune cells from skin, blood and Cerebrospinal fluid (CSF), before and after irradiation.